Skip to main content
Clinical Trials/IRCT20210524051384N8
IRCT20210524051384N8Not yet recruitingPhase 4

Evaluation of the effect of intravenous tranexamic acid on bleeding during burn surgery: a double blinded clinical trial

Rasht University of Medical Sciences0 sites82 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
82

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
All

Inclusion Criteria

  • patients age between 18 and 50
  • severe burn (TBSA>20%)
  • candidate for burn surgery

Exclusion Criteria

  • history of cardiovascular disease
  • Liver or kidney injury
  • pregnancy or lactating
  • occular pathologies
  • different coagulopathies
  • history of allergy to Tranexamic acid

Investigators

Sponsor
Rasht University of Medical Sciences

Similar Trials